FDA accepts Amoxicillin Pulsys NDA

Advancis (AVNC) gained $0.37 (14%) to $3.10 on Tuesday after FDA accepted for filing an NDA for once-daily Amoxicillin Pulsys to treat adolescents and adults with pharyngitis/tonsillitis. The PDUFA da...